On 6 May 2016, the Government published its response to ACIP’s review of designs law. Who knew? ACIP came up with 23 recommendations. For the most part, the Government accepted ACIP’s recommendations.
The Government has accepted almost all of the Harper Review’s recommendations including the power to block parallel imports of books.
Minister announce Productivity Commission to review Australia’s IP laws
The Advisory Council on Intellectual Property (ACIP) has released an options paper for arising from its Review of the (Registered) Designs System.
auDA, the body which administers the domain name system in the .au (i.e. Australia) space (OK, ccTLD) has embarked on a review (pdf) of its WhoIS policy. There are 2 main issues: Should there be any changes to auDA’s WHOIS Policy covering the collection, disclosure and use of WHOIS data for .au domain names? Should access to .au domain name data (other than via WHOIS) be opened up? Apparently, there was a.. Read More
ACIP has published an issues paper reviewing the operation of the Designs Act 2003 for the first time since it came into force.
ACIP has released an options paper on what to do about the innovation patent system and raised 3 options for comment …
auda is conducting a review of the auDRP – the dispute resolution policy covering domain names registered in the .au domain name space. The auDRP was derived from the UDRP, so many of the principles worked out under the latter are equally applicable under the auDRP. Two of the main differences, however, are that under the auDRP: a complainant may have rights sufficient to found a complaint “in a name”,.. Read More
Last month, the Parliamentary Secretary for Industry and Innovation, Mark Dreyfus, has appointed a panel to review the patenting of pharmaceuticals in Australia. Now the Panel have published a Background and Issues Paper. The Panel’s initial impressions of key issues include: a number of concerns have been raised about the length and breadth of protection provided by the extension of term provisions, that is, the duration of the extension and the.. Read More
The Parliamentary Secretary for Industry and Innovation, Mark Dreyfus, has appointed a panel to review the patenting of pharmaceuticals in Australia. According to the Terms of Reference, the review: will evaluate whether the system for pharmaceutical patents is effectively balancing the objectives of securing timely access to competitively priced pharmaceuticals, fostering innovation and supporting employment in research and industry. Central to this will be an analysis of the pharmaceutical extension of.. Read More